(Q43754593)

26 November 2017

Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis (English)

1 reference

26 November 2017

Pseudomonas aeruginosa

0 references

0 references

1

1 reference

26 November 2017

G Döring

2

1 reference

PubMed ID

11583754

26 November 2017

W H Nikolaizik

series ordinal

3

1 reference

PubMed ID

11583754

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

358

1 reference

26 November 2017

983-984

1 reference

26 November 2017

9286

1 reference

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906124-4

7 January 2021

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906124-4

7 January 2021

Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906124-4

7 January 2021

Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906124-4

7 January 2021

10.1016/S0140-6736(01)06124-4

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11583754